We also show that the elevated SAA level in breast cancer cells is associated with more advanced lymph node stage and lymphovascular invasion in breast cancer patients, while SAA immunoreactivity in TAM associated with almost all the important clinicopathological parameters. The gene discussed is SAA1; the disease is breast carcinoma.